๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Are all melanomas the same? : Spitzoid melanoma is a distinct subtype of melanoma

โœ Scribed by David A. Lee; Jason A. Cohen; William S. Twaddell; Gustavo Palacios; Melissa Gill; Eyal Levit; Alan J. Halperin; Joan Mones; Klaus J. Busam; David N. Silvers; Julide Tok Celebi

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
192 KB
Volume
106
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Variants of the MATP/SLC45A2 gene are pr
Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population
โœ Mickaรซl Guedj; Agnรจs Bourillon; Christophe Combadiรจres; Mathieu Rodero; Philippe ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

In this study, we investigated whether variants in three key pigmentation genes-MC1R, MATP/SLC45A2, and OCA2--were involved in melanoma predisposition. A cohort comprising 1,019 melanoma patients (MelanCohort) and 1,466 Caucasian controls without skin cancers were studied. A total of 10 polymorphism

A member of the melanoma antigen-encodin
A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing
โœ Jรผrgen C. Becker; Reinhard Gillitzer; Eva-Bettina Brรถcker ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 428 KB

MACE-I has been identified as a human gene, which directs the expression of an antigen being recognized on melanoma cells by autologous cytolytic T cells. MACE-I is expressed in melanomas and some other tumors. It has been proposed that this gene may be linked to the transformation event and therefo

The kinetics of the visible growth of a
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: A prospective study
โœ Jean Jacques Grob; Marie Aleth Richard; Johany Gouvernet; Marie Franรงoise Avril; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 90 KB

## Abstract Primary melanoma (MM) could be a good model to test an intuitive concept: a cancer that is growing fast in its early phase is likely to have a high aggressiveness. Since MMs are visible tumors, many patients can provide information to indirectly assess the kinetics of their lesion. A pr